| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivator 3 | 34 | 2024 | 351 | 5.090 |
Why?
|
| Nuclear Receptor Coactivator 1 | 13 | 2021 | 244 | 1.980 |
Why?
|
| Trans-Activators | 15 | 2015 | 840 | 1.540 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 8 | 2012 | 396 | 1.360 |
Why?
|
| Nuclear Receptor Coactivator 2 | 10 | 2025 | 211 | 1.310 |
Why?
|
| Nuclear Receptor Coactivators | 7 | 2024 | 76 | 1.290 |
Why?
|
| Antineoplastic Agents | 11 | 2024 | 1853 | 1.210 |
Why?
|
| Proteasome Endopeptidase Complex | 15 | 2020 | 278 | 1.070 |
Why?
|
| Receptors, Steroid | 6 | 2022 | 276 | 0.940 |
Why?
|
| Neoplasms | 8 | 2024 | 3038 | 0.930 |
Why?
|
| Transcriptional Activation | 11 | 2024 | 504 | 0.920 |
Why?
|
| Transcription, Genetic | 16 | 2023 | 1761 | 0.870 |
Why?
|
| Ubiquitin | 7 | 2009 | 151 | 0.860 |
Why?
|
| Cell Line, Tumor | 31 | 2024 | 3798 | 0.830 |
Why?
|
| Transcription Factors | 11 | 2022 | 2738 | 0.810 |
Why?
|
| Repressor Proteins | 8 | 2021 | 874 | 0.800 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 296 | 0.770 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 1012 | 0.740 |
Why?
|
| Bufanolides | 3 | 2015 | 17 | 0.690 |
Why?
|
| Receptors, Estrogen | 10 | 2019 | 830 | 0.680 |
Why?
|
| Signal Transduction | 15 | 2024 | 4934 | 0.650 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2017 | 101 | 0.650 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2021 | 2137 | 0.640 |
Why?
|
| Breast Neoplasms | 11 | 2023 | 2771 | 0.630 |
Why?
|
| Stress, Physiological | 2 | 2019 | 272 | 0.630 |
Why?
|
| Cell Proliferation | 13 | 2024 | 2563 | 0.620 |
Why?
|
| Gene Expression Regulation | 16 | 2023 | 2669 | 0.610 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2019 | 277 | 0.600 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 129 | 0.590 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2025 | 247 | 0.580 |
Why?
|
| Animals | 52 | 2025 | 36557 | 0.560 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 698 | 0.560 |
Why?
|
| MCF-7 Cells | 8 | 2021 | 233 | 0.510 |
Why?
|
| Histone Acetyltransferases | 8 | 2008 | 319 | 0.500 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 407 | 0.490 |
Why?
|
| Drug Design | 1 | 2017 | 168 | 0.490 |
Why?
|
| Estrogen Receptor alpha | 11 | 2018 | 475 | 0.490 |
Why?
|
| Genomics | 2 | 2022 | 1681 | 0.490 |
Why?
|
| Mice | 33 | 2025 | 19055 | 0.470 |
Why?
|
| Proteolysis | 3 | 2014 | 199 | 0.450 |
Why?
|
| Autoantigens | 5 | 2020 | 118 | 0.450 |
Why?
|
| Trichothecenes | 1 | 2014 | 4 | 0.450 |
Why?
|
| Cell Movement | 6 | 2025 | 920 | 0.430 |
Why?
|
| Nuclear Proteins | 8 | 2020 | 1351 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2024 | 825 | 0.420 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2014 | 111 | 0.420 |
Why?
|
| Humans | 74 | 2025 | 134156 | 0.390 |
Why?
|
| Selective Estrogen Receptor Modulators | 2 | 2004 | 63 | 0.390 |
Why?
|
| HeLa Cells | 15 | 2015 | 838 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 797 | 0.360 |
Why?
|
| Chromatin | 3 | 2018 | 617 | 0.350 |
Why?
|
| Tamoxifen | 3 | 2023 | 377 | 0.340 |
Why?
|
| Embryo Implantation | 2 | 2023 | 235 | 0.310 |
Why?
|
| Chromosome Positioning | 1 | 2008 | 3 | 0.290 |
Why?
|
| Multifactorial Inheritance | 1 | 2009 | 168 | 0.290 |
Why?
|
| Proteasome Inhibitors | 4 | 2021 | 66 | 0.290 |
Why?
|
| Disease | 1 | 2009 | 133 | 0.290 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 719 | 0.290 |
Why?
|
| Uterus | 2 | 2023 | 587 | 0.270 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2009 | 464 | 0.260 |
Why?
|
| Energy Metabolism | 5 | 2022 | 814 | 0.260 |
Why?
|
| Ligands | 5 | 2023 | 572 | 0.250 |
Why?
|
| Oxidative Stress | 3 | 2024 | 877 | 0.250 |
Why?
|
| Protein Binding | 10 | 2018 | 1859 | 0.250 |
Why?
|
| Cell Survival | 8 | 2025 | 890 | 0.240 |
Why?
|
| Metabolic Diseases | 1 | 2007 | 139 | 0.240 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 249 | 0.240 |
Why?
|
| Cell Nucleus | 3 | 2010 | 691 | 0.240 |
Why?
|
| Models, Genetic | 2 | 2007 | 789 | 0.230 |
Why?
|
| Stromal Cells | 3 | 2022 | 313 | 0.230 |
Why?
|
| Endometrium | 4 | 2023 | 289 | 0.230 |
Why?
|
| Homeostasis | 3 | 2020 | 751 | 0.230 |
Why?
|
| Estrogens | 5 | 2018 | 525 | 0.220 |
Why?
|
| Trophoblasts | 1 | 2025 | 119 | 0.220 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2016 | 384 | 0.220 |
Why?
|
| Female | 32 | 2025 | 71928 | 0.220 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2004 | 18 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2024 | 31 | 0.220 |
Why?
|
| Hydrogen Peroxide | 1 | 2024 | 131 | 0.210 |
Why?
|
| Adenine | 1 | 2024 | 122 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2023 | 322 | 0.210 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 131 | 0.200 |
Why?
|
| Cyclohexanones | 2 | 2020 | 19 | 0.200 |
Why?
|
| Th17 Cells | 1 | 2024 | 100 | 0.200 |
Why?
|
| Gene Editing | 1 | 2025 | 213 | 0.200 |
Why?
|
| Receptors, Androgen | 2 | 2024 | 433 | 0.200 |
Why?
|
| Mice, Knockout | 10 | 2023 | 4016 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2024 | 928 | 0.190 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2022 | 39 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 142 | 0.190 |
Why?
|
| Phosphorylation | 6 | 2020 | 1713 | 0.190 |
Why?
|
| RNA | 2 | 2023 | 607 | 0.190 |
Why?
|
| Forkhead Transcription Factors | 2 | 2022 | 390 | 0.190 |
Why?
|
| Immunity | 1 | 2022 | 187 | 0.190 |
Why?
|
| Genes, Reporter | 3 | 2017 | 398 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 8 | 2023 | 1433 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 2 | 2022 | 1089 | 0.180 |
Why?
|
| Pyridines | 2 | 2020 | 250 | 0.180 |
Why?
|
| Drug Synergism | 2 | 2019 | 242 | 0.180 |
Why?
|
| Proteomics | 3 | 2018 | 599 | 0.180 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 19 | 0.170 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 149 | 0.170 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 30 | 0.170 |
Why?
|
| Oncogenes | 1 | 2021 | 181 | 0.170 |
Why?
|
| Gene Expression | 3 | 2016 | 1621 | 0.170 |
Why?
|
| Ubiquitin-Specific Proteases | 2 | 2018 | 22 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 104 | 0.170 |
Why?
|
| Phospholipids | 1 | 2020 | 114 | 0.170 |
Why?
|
| Circadian Clocks | 1 | 2020 | 72 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 191 | 0.160 |
Why?
|
| Glucose | 2 | 2015 | 927 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 3 | 2009 | 119 | 0.160 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 721 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 176 | 0.160 |
Why?
|
| Reproduction | 2 | 2013 | 245 | 0.160 |
Why?
|
| HEK293 Cells | 6 | 2020 | 825 | 0.160 |
Why?
|
| Models, Biological | 5 | 2011 | 1539 | 0.160 |
Why?
|
| Salivary Glands | 1 | 2019 | 35 | 0.160 |
Why?
|
| Endometriosis | 1 | 2022 | 186 | 0.160 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 149 | 0.160 |
Why?
|
| Transcriptome | 3 | 2025 | 1138 | 0.150 |
Why?
|
| RANK Ligand | 1 | 2019 | 54 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 609 | 0.150 |
Why?
|
| Myocardium | 1 | 2024 | 1046 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 388 | 0.150 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2019 | 67 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2018 | 18 | 0.150 |
Why?
|
| DNA | 2 | 2016 | 1682 | 0.150 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 202 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 352 | 0.150 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2018 | 12 | 0.140 |
Why?
|
| Cell Line | 6 | 2025 | 2864 | 0.140 |
Why?
|
| Small Molecule Libraries | 2 | 2017 | 138 | 0.140 |
Why?
|
| Benzimidazoles | 2 | 2016 | 136 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 596 | 0.140 |
Why?
|
| Liver | 2 | 2022 | 1879 | 0.140 |
Why?
|
| Drug Resistance, Multiple | 1 | 2017 | 52 | 0.130 |
Why?
|
| Infertility | 1 | 2018 | 82 | 0.130 |
Why?
|
| Mice, SCID | 5 | 2018 | 615 | 0.130 |
Why?
|
| Wound Healing | 1 | 2021 | 488 | 0.130 |
Why?
|
| Decidua | 1 | 2018 | 142 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 167 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2011 | 393 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 510 | 0.130 |
Why?
|
| Cytokines | 1 | 2022 | 1401 | 0.130 |
Why?
|
| Hydrazones | 1 | 2016 | 19 | 0.130 |
Why?
|
| Lysosomes | 1 | 2018 | 265 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 4879 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 51 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 298 | 0.120 |
Why?
|
| Mice, Nude | 4 | 2020 | 780 | 0.120 |
Why?
|
| beta Catenin | 1 | 2017 | 232 | 0.120 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2015 | 7 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 64 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 429 | 0.120 |
Why?
|
| Twist-Related Protein 1 | 1 | 2015 | 39 | 0.120 |
Why?
|
| Luciferases | 1 | 2015 | 139 | 0.120 |
Why?
|
| Multiprotein Complexes | 3 | 2013 | 219 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 299 | 0.110 |
Why?
|
| Acetyltransferases | 2 | 2006 | 92 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 316 | 0.110 |
Why?
|
| Receptors, Progesterone | 5 | 2009 | 898 | 0.110 |
Why?
|
| RNA Splicing | 2 | 2007 | 252 | 0.110 |
Why?
|
| Protein Stability | 5 | 2014 | 174 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2020 | 92 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 316 | 0.110 |
Why?
|
| Oncogene Proteins | 2 | 2006 | 157 | 0.110 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 46 | 0.110 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2014 | 52 | 0.110 |
Why?
|
| NAD | 1 | 2014 | 51 | 0.110 |
Why?
|
| RNA, Messenger | 6 | 2023 | 2915 | 0.110 |
Why?
|
| Binding Sites | 5 | 2018 | 1384 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 468 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2013 | 40 | 0.100 |
Why?
|
| Leupeptins | 5 | 2011 | 26 | 0.100 |
Why?
|
| Response Elements | 1 | 2013 | 107 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2013 | 18 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1102 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 738 | 0.100 |
Why?
|
| Progesterone | 2 | 2005 | 635 | 0.090 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 559 | 0.090 |
Why?
|
| Gossypol | 1 | 2011 | 5 | 0.090 |
Why?
|
| Cullin Proteins | 1 | 2011 | 15 | 0.090 |
Why?
|
| Multienzyme Complexes | 2 | 2003 | 89 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2009 | 231 | 0.090 |
Why?
|
| Fibrosis | 2 | 2024 | 463 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 622 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 178 | 0.080 |
Why?
|
| Transfection | 4 | 2017 | 1096 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 132 | 0.080 |
Why?
|
| Disease Progression | 1 | 2016 | 2266 | 0.080 |
Why?
|
| Histones | 2 | 2021 | 573 | 0.080 |
Why?
|
| Ligases | 2 | 2000 | 48 | 0.080 |
Why?
|
| Mitochondria | 1 | 2015 | 757 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2018 | 1107 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 470 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2020 | 2045 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 675 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 2539 | 0.080 |
Why?
|
| Hormones | 1 | 2010 | 198 | 0.080 |
Why?
|
| Selection, Genetic | 1 | 2009 | 169 | 0.080 |
Why?
|
| Cell Cycle | 3 | 2020 | 628 | 0.080 |
Why?
|
| Steroids | 1 | 2010 | 213 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2023 | 937 | 0.070 |
Why?
|
| RNA Interference | 3 | 2018 | 548 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 377 | 0.070 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 116 | 0.070 |
Why?
|
| Translocation, Genetic | 2 | 2021 | 363 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1332 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 151 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2022 | 482 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2003 | 41 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2011 | 720 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 2178 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2018 | 259 | 0.060 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 33 | 0.060 |
Why?
|
| Ubiquitination | 3 | 2013 | 186 | 0.060 |
Why?
|
| Apoptosis | 2 | 2024 | 1946 | 0.060 |
Why?
|
| Pregnancy | 3 | 2025 | 7570 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 1787 | 0.060 |
Why?
|
| Placentation | 1 | 2025 | 61 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2005 | 102 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2008 | 2795 | 0.060 |
Why?
|
| Syndrome | 1 | 2007 | 1167 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 951 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2008 | 633 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2015 | 319 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 1626 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 3980 | 0.050 |
Why?
|
| Mammals | 2 | 2022 | 282 | 0.050 |
Why?
|
| Male | 8 | 2023 | 66127 | 0.050 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2003 | 23 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2006 | 915 | 0.050 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2003 | 42 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 611 | 0.050 |
Why?
|
| Mutation | 5 | 2018 | 6338 | 0.050 |
Why?
|
| Piperidines | 1 | 2024 | 240 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2017 | 108 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 773 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2015 | 320 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 90 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 331 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 746 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 88 | 0.040 |
Why?
|
| RNA, Untranslated | 1 | 2002 | 120 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2011 | 1140 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2021 | 59 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2002 | 443 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 57 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 47 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2024 | 418 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 71 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2021 | 74 | 0.040 |
Why?
|
| cdc25 Phosphatases | 1 | 2020 | 20 | 0.040 |
Why?
|
| Estradiol | 2 | 2000 | 559 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 806 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2021 | 103 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 249 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 206 | 0.040 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 1 | 2020 | 21 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 324 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 201 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 228 | 0.040 |
Why?
|
| Ubiquitins | 1 | 1999 | 46 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2021 | 311 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2018 | 28 | 0.040 |
Why?
|
| Lipids | 1 | 2022 | 566 | 0.040 |
Why?
|
| Epithelium | 1 | 2019 | 366 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2018 | 46 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1999 | 74 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 894 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2020 | 372 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 2018 | 47 | 0.040 |
Why?
|
| Rats | 1 | 2024 | 3890 | 0.030 |
Why?
|
| Luminescence | 1 | 2017 | 18 | 0.030 |
Why?
|
| Proteins | 1 | 2003 | 1101 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1599 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1472 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 529 | 0.030 |
Why?
|
| Doxycycline | 1 | 2017 | 121 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3506 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 711 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 90 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 1440 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2015 | 153 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 111 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 131 | 0.030 |
Why?
|
| Kinetics | 2 | 2011 | 1357 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 224 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 33 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 366 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 44 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 218 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 48 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 22 | 0.030 |
Why?
|
| Tetrazolium Salts | 1 | 2013 | 15 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 71 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 245 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 271 | 0.030 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2013 | 19 | 0.030 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2013 | 58 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 289 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 99 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 311 | 0.030 |
Why?
|
| Lentivirus | 1 | 2013 | 87 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1595 | 0.020 |
Why?
|
| Thiazoles | 1 | 2013 | 104 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2013 | 119 | 0.020 |
Why?
|
| Computational Biology | 1 | 2018 | 890 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 535 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 68 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 90 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 399 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3188 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2011 | 45 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 873 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 399 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1044 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 548 | 0.020 |
Why?
|
| Animal Structures | 1 | 2010 | 14 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 324 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 152 | 0.020 |
Why?
|
| Substrate Specificity | 2 | 2002 | 313 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 449 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2010 | 304 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 390 | 0.020 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2009 | 13 | 0.020 |
Why?
|
| RNA Stability | 1 | 2010 | 87 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7217 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 970 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 145 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2013 | 834 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 104 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 108 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 947 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1071 | 0.020 |
Why?
|
| Trefoil Factor-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Testis | 1 | 2010 | 433 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2007 | 24 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 153 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2007 | 106 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 174 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2007 | 38 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 787 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 230 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2006 | 8 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 673 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 1077 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2005 | 3 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2005 | 80 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 18 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2005 | 38 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 55 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2007 | 262 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1071 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2003 | 66 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 6610 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 709 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21775 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 1421 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 29399 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 774 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 31945 | 0.010 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 1999 | 87 | 0.010 |
Why?
|
| RNA, Long Noncoding | 1 | 2002 | 250 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1999 | 87 | 0.010 |
Why?
|
| Arabidopsis | 1 | 1999 | 94 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 672 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 912 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 993 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 3180 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1999 | 1027 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 4598 | 0.000 |
Why?
|